Variant report

Variant	nsv1027705
Chromosome Location	chr9:6784659-6863403
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:6788815-6789003	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:6819233-6819386	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:6787981-6788483	HepG2	liver:	n/a	n/a
4	ARID3A	chr9:6845932-6846244	HepG2	liver:	n/a	n/a
5	ARID3A	chr9:6845117-6845374	HepG2	liver:	n/a	n/a
6	BACH1	chr9:6854906-6854915	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr9:6816627-6816816	GM12878	blood:	n/a	n/a
8	BHLHE40	chr9:6787901-6788385	HepG2	liver:	n/a	n/a
9	BHLHE40	chr9:6788713-6789019	HepG2	liver:	n/a	n/a
10	BHLHE40	chr9:6845885-6846304	HepG2	liver:	n/a	n/a
11	CEBPB	chr9:6845149-6845367	K562	blood:	n/a	chr9:6845269-6845280
12	CEBPB	chr9:6791899-6792074	HepG2	liver:	n/a	chr9:6791972-6791983
13	CEBPB	chr9:6845100-6845379	IMR90	lung:	n/a	chr9:6845269-6845280
14	CEBPB	chr9:6793793-6794137	IMR90	lung:	n/a	chr9:6793948-6793959
15	CEBPB	chr9:6845142-6845388	H1-hESC	embryonic stem cell:	n/a	chr9:6845269-6845280
16	CEBPB	chr9:6793884-6794068	H1-hESC	embryonic stem cell:	n/a	chr9:6793948-6793959
17	CEBPB	chr9:6837817-6838082	HepG2	liver:	n/a	chr9:6837935-6837946
18	CEBPB	chr9:6793835-6794105	HepG2	liver:	n/a	chr9:6793948-6793959
19	CEBPB	chr9:6797383-6797661	HepG2	liver:	n/a	n/a
20	CEBPB	chr9:6845072-6845462	HepG2	liver:	n/a	chr9:6845269-6845280
21	CEBPB	chr9:6845120-6845326	A549	lung:	n/a	chr9:6845269-6845280
22	CEBPB	chr9:6833914-6834218	A549	lung:	n/a	n/a
23	CEBPB	chr9:6833910-6834257	IMR90	lung:	n/a	n/a
24	CEBPB	chr9:6845080-6845466	HepG2	liver:	n/a	chr9:6845269-6845280
25	CEBPB	chr9:6833935-6834181	K562	blood:	n/a	n/a
26	CEBPB	chr9:6793836-6794137	A549	lung:	n/a	chr9:6793948-6793959
27	CEBPB	chr9:6855379-6855455	A549	lung:	n/a	chr9:6855409-6855420
28	CEBPB	chr9:6837930-6837971	A549	lung:	n/a	chr9:6837935-6837946
29	CEBPB	chr9:6797447-6797583	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr9:6845142-6845308	Hela-S3	cervix:	n/a	chr9:6845269-6845280
31	CEBPB	chr9:6845058-6845486	HepG2	liver:	n/a	chr9:6845269-6845280
32	CEBPB	chr9:6793815-6794098	K562	blood:	n/a	chr9:6793948-6793959
33	CEBPB	chr9:6855320-6855457	HepG2	liver:	n/a	chr9:6855409-6855420
34	CEBPB	chr9:6797470-6797589	K562	blood:	n/a	n/a
35	CEBPB	chr9:6845155-6845343	HepG2	liver:	n/a	chr9:6845269-6845280
36	CEBPB	chr9:6827408-6827673	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr9:6797435-6797552	HepG2	liver:	n/a	n/a
38	CEBPD	chr9:6845083-6845422	HepG2	liver:	n/a	n/a
39	CEBPD	chr9:6845166-6845369	HepG2	liver:	n/a	n/a
40	CHD1	chr9:6827620-6827645	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr9:6845936-6846168	MCF-7	breast:	n/a	chr9:6846078-6846087
42	CTCF	chr9:6829140-6829290	HVMF	connective:	n/a	n/a
43	CTCF	chr9:6827460-6827610	HUVEC	blood vessel:	n/a	chr9:6827536-6827557 chr9:6827537-6827550 chr9:6827534-6827552
44	CTCF	chr9:6846020-6846170	HCT-116	colon:	n/a	chr9:6846078-6846087
45	CTCF	chr9:6829060-6829210	HRPEpiC	eye:	n/a	n/a
46	CTCF	chr9:6827460-6827610	AG10803	skin:	n/a	chr9:6827536-6827557 chr9:6827537-6827550 chr9:6827534-6827552
47	CTCF	chr9:6846020-6846170	AoAF	blood vessel:	n/a	chr9:6846078-6846087
48	CTCF	chr9:6827440-6827590	Caco-2	colon:	n/a	chr9:6827536-6827557 chr9:6827537-6827550 chr9:6827534-6827552
49	CTCF	chr9:6827445-6827648	GM10266	blood:	n/a	chr9:6827536-6827557 chr9:6827537-6827550 chr9:6827534-6827552
50	CTCF	chr9:6827460-6827610	AoAF	blood vessel:	n/a	chr9:6827536-6827557 chr9:6827537-6827550 chr9:6827534-6827552

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:6835001-6835051	NHBE	bronchial:	n/a
2	chr9:6836634-6836684	CMK	blood:	n/a
3	chr9:6835001-6835051	MCF-7	breast:	n/a
4	chr9:6836634-6836684	AG10803	skin:	n/a
5	chr9:6836634-6836684	GM12891	blood:	n/a
6	chr9:6836634-6836684	HCM	heart:	n/a
7	chr9:6836634-6836684	SAEC	small airway:	n/a
8	chr9:6836634-6836684	MCF-7	breast:	n/a
9	chr9:6835001-6835051	HRPEpiC	eye:	n/a
10	chr9:6836634-6836684	Hepatocyte	liver:	n/a
11	chr9:6836634-6836684	AoSMC	blood vessel:	n/a
12	chr9:6835001-6835051	HAEpiC	amniotic membrane:	n/a
13	chr9:6835001-6835051	GM06990	blood:	n/a
14	chr9:6836634-6836684	HRPEpiC	eye:	n/a
15	chr9:6836634-6836684	BE2_C	brain:	n/a
16	chr9:6835001-6835051	AG04450	lung:	fetal
17	chr9:6836634-6836684	HAEpiC	amniotic membrane:	n/a
18	chr9:6835001-6835051	GM12878	blood:	n/a
19	chr9:6836634-6836684	MCF10A-Er-Src	breast:	n/a
20	chr9:6836634-6836684	K562	blood:	n/a
21	chr9:6836634-6836684	RPTEC	kidney:	n/a
22	chr9:6835001-6835051	HNPCEpiC	eye:	n/a
23	chr9:6835001-6835051	A549	lung:	n/a
24	chr9:6836634-6836684	NHDF-neo	bronchial:	n/a
25	chr9:6836634-6836684	NB4	blood:	n/a
26	chr9:6835001-6835051	PANC-1	pancreas:	n/a
27	chr9:6836634-6836684	U87	brain:	n/a
28	chr9:6835001-6835051	PrEC	prostate:	n/a
29	chr9:6836634-6836684	IMR90	lung:	fetal
30	chr9:6836634-6836684	ECC-1	luminal epithelium:	n/a
31	chr9:6835001-6835051	K562	blood:	n/a
32	chr9:6835001-6835051	NHDF-neo	bronchial:	n/a
33	chr9:6836634-6836684	ProgFib	skin:	n/a
34	chr9:6835001-6835051	RPTEC	kidney:	n/a
35	chr9:6835001-6835051	AG09309	skin:	n/a
36	chr9:6836634-6836684	HCT-116	colon:	n/a
37	chr9:6835001-6835051	SK-N-SH	brain:	n/a
38	chr9:6835001-6835051	AG04449	skin:	fetal
39	chr9:6836634-6836684	HPAEpiC	pulmonary alveolar:	n/a
40	chr9:6836634-6836684	T-47D	breast:	n/a
41	chr9:6835001-6835051	SK-N-SH_RA	brain:	n/a
42	chr9:6836634-6836684	HL-60	blood:	n/a
43	chr9:6836634-6836684	HIPEpiC	eye:	n/a
44	chr9:6835001-6835051	HEEpiC	esophagus:	n/a
45	chr9:6836634-6836684	BJ	skin:	n/a
46	chr9:6836634-6836684	SKMC	muscle:	n/a
47	chr9:6835001-6835051	BE2_C	brain:	n/a
48	chr9:6836634-6836684	AG04449	skin:	fetal
49	chr9:6835001-6835051	HEK293	kidney:	embryo
50	chr9:6835001-6835051	H1-hESC	embryonic stem cell:	embryo

No.	Distal block	Cell Line	Cell type
1	chr9:6845574..6847293-chr9:6858590..6860659,2	K562	blood:
2	chr9:6680103..6682666-chr9:6784102..6786978,2	K562	blood:
3	chr9:6842488..6845236-chr9:6852172..6854079,2	MCF-7	breast:
4	chr9:6831771..6833427-chr9:6836426..6839172,2	K562	blood:
5	chr9:6826110..6829506-chr9:6834474..6836178,3	MCF-7	breast:
6	chr9:6845574..6847293-chr9:6858590..6860659,2	K562	blood:
7	chr9:6831771..6833427-chr9:6836426..6839172,2	K562	blood:
8	chr9:6757938..6759489-chr9:6817335..6820629,3	MCF-7	breast:
9	chr9:6826110..6829506-chr9:6834474..6836178,3	MCF-7	breast:
10	chr9:6842488..6845236-chr9:6852172..6854079,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UHRF2-1	chr9:6785601-6785929	ENSG00000236563.1

Variant related genes	Relation type
ENSG00000230581	TF binding region
KDM4C	TF binding region
ENSG00000230581	CpG island
KDM4C	CpG island
ENSG00000107077	chromatin interactions

Extended variants
information (count: 4370 )
Associated
traits (count: 104 )

Variant overlapped rSNPs/rCNVs (count:4370 , 50 per page) page: 1 2 3 4 5 6 7 ... 88

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10975827	chr9:6784659-6784660	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs570532283	chr9:6784667-6784668	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs375742441	chr9:6784669-6784670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs377042332	chr9:6784684-6784685	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs111274943	chr9:6784685-6784686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs575274961	chr9:6784700-6784701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs182488737	chr9:6784720-6784721	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs568686867	chr9:6784722-6784723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs10815468	chr9:6784726-6784727	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	disease
10	rs553921153	chr9:6784761-6784762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs541196343	chr9:6784762-6784763	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs554137092	chr9:6784790-6784791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs373832712	chr9:6784818-6784819	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs186729936	chr9:6784845-6784846	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs539401975	chr9:6784862-6784863	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs17593759	chr9:6784867-6784868	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs576096475	chr9:6784873-6784874	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs544115694	chr9:6784908-6784909	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs367772651	chr9:6784932-6784933	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs556304518	chr9:6784954-6784955	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs574692002	chr9:6784983-6784984	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs542115234	chr9:6784999-6785000	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs369534249	chr9:6785013-6785014	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs192048134	chr9:6785046-6785047	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs372663481	chr9:6785069-6785070	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs527303728	chr9:6785074-6785075	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs144066568	chr9:6785078-6785079	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs540480864	chr9:6785083-6785084	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs564202872	chr9:6785091-6785092	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs11792706	chr9:6785149-6785150	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs550153222	chr9:6785227-6785228	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs11792731	chr9:6785228-6785229	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs11795163	chr9:6785235-6785236	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs11794756	chr9:6785243-6785244	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs566004243	chr9:6785257-6785258	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs539466651	chr9:6785281-6785282	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs557718505	chr9:6785295-6785296	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs34317428	chr9:6785298-6785299	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs377148655	chr9:6785313-6785314	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs77128731	chr9:6785316-6785317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs537551606	chr9:6785321-6785322	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs112696938	chr9:6785341-6785342	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs35762154	chr9:6785354-6785355	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs375340101	chr9:6785359-6785360	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs66560644	chr9:6785360-6785361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs181575242	chr9:6785365-6785366	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs554121713	chr9:6785384-6785385	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs572354643	chr9:6785429-6785430	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs545842100	chr9:6785431-6785432	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs564066426	chr9:6785481-6785482	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:104)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Developmental delay	21147756	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Metastatic melanoma	18483359	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Medulloblastoma	16783165	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD

Chromatin state (count:1983 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:6761800-6792800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
2	chr9:6772000-6788600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr9:6774200-6806200	Weak transcription	Aorta	Aorta
4	chr9:6775400-6785000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr9:6776200-6786200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
6	chr9:6776200-6786600	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr9:6776400-6786200	Enhancers	Primary B cells from peripheral blood	blood
8	chr9:6778800-6786200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr9:6779000-6789000	Enhancers	Primary T helper cells PMA-I stimulated	--
10	chr9:6779200-6785400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
11	chr9:6779400-6786000	Enhancers	Brain Hippocampus Middle	brain
12	chr9:6779400-6786200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
13	chr9:6779600-6787000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
14	chr9:6779600-6787400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr9:6779800-6787400	Weak transcription	Esophagus	oesophagus
16	chr9:6779800-6787600	Weak transcription	NHLF	lung
17	chr9:6779800-6788600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr9:6779800-6792800	Weak transcription	Ovary	ovary
19	chr9:6780000-6785000	Weak transcription	Liver	Liver
20	chr9:6780000-6785600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr9:6780200-6786000	Enhancers	Primary T cells fromperipheralblood	blood
22	chr9:6780200-6787400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr9:6780200-6787400	Weak transcription	Colonic Mucosa	Colon
24	chr9:6780200-6787600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr9:6780600-6785600	Weak transcription	A549	lung
26	chr9:6780600-6787600	Weak transcription	Rectal Smooth Muscle	rectum
27	chr9:6781000-6787200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr9:6781000-6787200	Weak transcription	HUVEC	blood vessel
29	chr9:6781200-6785800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
30	chr9:6781200-6786000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr9:6781200-6787400	Weak transcription	Osteobl	bone
32	chr9:6781200-6787600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr9:6781200-6787600	Weak transcription	Duodenum Smooth Muscle	Duodenum
34	chr9:6781200-6794000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
35	chr9:6781400-6784800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
36	chr9:6781400-6784800	Weak transcription	HUES6 Cell Line	embryonic stem cell
37	chr9:6781400-6785800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
38	chr9:6781400-6786400	Enhancers	Primary T helper naive cells from peripheral blood	blood
39	chr9:6781400-6787200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr9:6781600-6786600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr9:6781600-6787400	Enhancers	HepG2	liver
42	chr9:6781600-6787600	Weak transcription	HUES64 Cell Line	embryonic stem cell
43	chr9:6781800-6785800	Weak transcription	Fetal Intestine Large	intestine
44	chr9:6781800-6787200	Weak transcription	Rectal Mucosa Donor 31	rectum
45	chr9:6781800-6787400	Weak transcription	Rectal Mucosa Donor 29	rectum
46	chr9:6781800-6787400	Weak transcription	HMEC	breast
47	chr9:6781800-6788000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr9:6781800-6788000	Weak transcription	Colon Smooth Muscle	Colon
49	chr9:6782000-6786200	Enhancers	Fetal Thymus	thymus
50	chr9:6782200-6785000	Enhancers	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links